Lijun Rong

InstitutionUniversity of Illinois At Chicago
AddressChicago
Illinois
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 2 publications in February 2021
    All Publications
    Bar chart showing 71 publications over 20 distinct years, with a maximum of 9 publications in 2009
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Yang J, Perez EA, Hou C, Zhang P, Van Scoyk M, Winn RA, Rong L, Liu J. Identification of the SARS-CoV-2 Entry Receptor ACE2 as a Direct Target for Transcriptional Repression by Miz1. Front Immunol. 2021; 12:648815. PMID: 34305888.
      Citations:    Fields:    Translation:AnimalsCells
    2. Sarute N, Cheng H, Yan Z, Salas-Briceno K, Richner J, Rong L, Ross SR. Signal-regulatory protein alpha is an anti-viral entry factor targeting viruses using endocytic pathways. PLoS Pathog. 2021 06; 17(6):e1009662. PMID: 34097709.
      Citations: 2     Fields:    Translation:AnimalsCells
    3. Chen Z, Du R, Galvan Achi JM, Rong L, Cui Q. SARS-CoV-2 cell entry and targeted antiviral development. Acta Pharm Sin B. 2021 Dec; 11(12):3879-3888. PMID: 34002130.
      Citations: 1     
    4. Du R, Cooper L, Chen Z, Lee H, Rong L, Cui Q. Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CLpro. Antiviral Res. 2021 06; 190:105075. PMID: 33872675.
      Citations: 6     Fields:    Translation:AnimalsCells
    5. Chen Z, Cui Q, Cooper L, Zhang P, Lee H, Chen Z, Wang Y, Liu X, Rong L, Du R. Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases. Cell Biosci. 2021 Feb 28; 11(1):45. PMID: 33640032.
      Citations: 7     
    6. Anirudhan V, Lee H, Cheng H, Cooper L, Rong L. Targeting SARS-CoV-2 viral proteases as a therapeutic strategy to treat COVID-19. J Med Virol. 2021 05; 93(5):2722-2734. PMID: 33475167.
      Citations: 4     Fields:    Translation:HumansCells
    7. Kang Q, Wang Y, Cui Q, Gong L, Yang Y, Jiang H, Rong L, Rong R, Du R. Screening for Anti-Influenza Actives of Prefractionated Traditional Chinese Medicines. Evid Based Complement Alternat Med. 2020; 2020:4979850. PMID: 33123207.
      Citations: 2     
    8. Wang Y, Anirudhan V, Du R, Cui Q, Rong L. RNA-dependent RNA polymerase of SARS-CoV-2 as a therapeutic target. J Med Virol. 2021 01; 93(1):300-310. PMID: 32633831.
      Citations: 23     Fields:    
    9. Liu X, Wu Y, Rong L. Conditionally Reprogrammed Human Normal Airway Epithelial Cells at ALI: A Physiological Model for Emerging Viruses. Virol Sin. 2020 Jun; 35(3):280-289. PMID: 32557270.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    10. Guo Y, Tisoncik J, McReynolds S, Farzan M, Prabhakar BS, Gallagher T, Rong L, Caffrey M. Identification of a new region of SARS-CoV S protein critical for viral entry. J Mol Biol. 2009 Dec 11; 394(4):600-5. PMID: 19853613.
      Citations: 21     Fields:    Translation:HumansCells
    11. McReynolds S, Jiang S, Rong L, Caffrey M. Dynamics of SARS-coronavirus HR2 domain in the prefusion and transition states. J Magn Reson. 2009 Dec; 201(2):218-21. PMID: 19819173.
      Citations: 3     Fields:    Translation:Cells
    12. McReynolds S, Jiang S, Guo Y, Celigoy J, Schar C, Rong L, Caffrey M. Characterization of the prefusion and transition states of severe acute respiratory syndrome coronavirus S2-HR2. Biochemistry. 2008 Jul 01; 47(26):6802-8. PMID: 18540634.
      Citations: 15     Fields:    Translation:Cells
    13. Hakansson-McReynolds S, Jiang S, Rong L, Caffrey M. Solution structure of the severe acute respiratory syndrome-coronavirus heptad repeat 2 domain in the prefusion state. J Biol Chem. 2006 Apr 28; 281(17):11965-71. PMID: 16507566.
      Citations: 25     Fields:    Translation:HumansCells